Učitavanje...
Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
Objective: To compare the treatment costs of insulin glargine (IG; Lantus(®)) to detemir (ID; Levemir(®)), both combined with bolus insulin aspart (NovoRapid(®)) in type 2 diabetes (T2D) in Germany. Methods: Cost comparison was based on data of a 1-year randomised controlled trial [1]. IG was admini...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
German Medical Science GMS Publishing House
2010
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921814/ https://ncbi.nlm.nih.gov/pubmed/20725588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3205/000106 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|